Quartet of APOCs and the Different Roles They Play in Diabetes
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023
DOI: 10.1161/atvbaha.122.318290 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023. Verfasst von Cheng-Chieh Hsu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism, Endocrinology and Nutrition, Department of Medicine (C.C.H., J.E.K., V.K., K.E.B.), University of Washington Medicine Diabete…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Atherosclerosis, Insulins. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
APOA1 and APOB are the structural proteins of high-density lipoprotein and APOB-containing lipoproteins, such as low-density lipoprotein and very low-density lipoprotein, respectively. The 4 smaller APOCs (APOC1, APOC2, APOC3, and APOC4) are exchangeable apolipoproteins; they are readily transferred among high-density lipoproteins and APOB-containing lipoproteins. The APOCs regulate plasma triglyceride and cholesterol levels by modulating substrate availability and activities of enzymes interacting with lipoproteins and by interfering with APOB-containing lipoprotein uptake through hepatic receptors. Of the 4 APOCs, APOC3 has been best studied in relation to diabetes. Elevated serum APOC3 levels predict incident cardiovascular disease and progression of kidney disease in people with type 1 diabetes. Insulin suppresses APOC3 levels, and accordingly, elevated APOC3 levels associate with insulin deficiency and insulin resistance. Mechanistic studies in a mouse model of type 1 diabetes have demonstrated that APOC3 acts in the causal pathway of diabetes-accelerated atherosclerosis. The mechanism is likely due to the ability of APOC3 to slow the clearance of triglyceride-rich lipoproteins and their remnants, thereby causing an increased accumulation of atherogenic lipoprotein remnants in lesions of atherosclerosis. Less is known about the roles of APOC1, APOC2, and APOC4 in diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Metabolism, Endocrinology and Nutrition, Department of Medicine (C.C.H., J.E.K., V.K., K.E.B.), University of Washington Medicine Diabetes Institute, University of Washington, Seattle.
- Department of Laboratory Medicine and Pathology (K.E.B.), University of Washington Medicine Diabetes Institute, University of Washington, Seattle.
ORCID-Profile: Jenny E Kanter, Vishal Kothari, Karin E Bornfeldt
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Hsu, C. C., Kanter, J. E., Kothari, V., & Bornfeldt, K. E. (2023). Quartet of APOCs and the Different Roles They Play in Diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.122.318290
Vancouver
Hsu CC, Kanter JE, Kothari V, Bornfeldt KE. Quartet of APOCs and the Different Roles They Play in Diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023. doi:10.1161/atvbaha.122.318290
BibTeX
@article{Hsu2023,
author = {Hsu, Cheng-Chieh and Kanter, Jenny E and Kothari, Vishal and Bornfeldt, Karin E},
title = {Quartet of APOCs and the Different Roles They Play in Diabetes},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
doi = {10.1161/atvbaha.122.318290}
}
EUVIMED